Nanoviricides NNVC
NYSE NNVC
$1.46 -0.05 (-3.08%)
As of: Oct 22, 2026 · 9:34 AM EDT

Nanoviricides (NNVC) Other Operating Expenses (2011 - 2025)

Updated

Nanoviricides (NNVC) recorded Other Operating Expenses of $2,000 in fiscal Q1 2026 (quarter ended Sep 30, 2025), unchanged from $2,000 a year earlier.

Analysis

Nanoviricides (NNVC) Other Operating Expenses (2011 - 2025) Analysis & Trends

Starting with fiscal Q3 2011, Nanoviricides' Other Operating Expenses history includes 12 quarters.

  • Annual Other Operating Expenses has a five-year compound annual growth rate of 0.0% (FY2020 to FY2025).
  • Across earlier fiscal years, Other Operating Expenses came in at $2,000 in FY2024 (unchanged), $2,000 in FY2023 (unchanged), $2,000 in FY2022 (unchanged) and $2,000 in FY2021 (unchanged).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,149.64 Bn 1,118.23 Bn 19.71 Bn
2 Johnson & Johnson 626.55 Bn 545.08 Bn 17.26 Bn
3 AbbVie 498.79 Bn 471.91 Bn 12.70 Bn
4 Merck 371.66 Bn 326.04 Bn 12.21 Bn
5 Novartis Ag 299.96 Bn 263.95 Bn 11.24 Bn
6 Astrazeneca 263.22 Bn 236.91 Bn 12.86 Bn
7 Amgen 237.03 Bn 192.43 Bn 7.24 Bn
8 Gilead Sciences 191.20 Bn 165.40 Bn 6.22 Bn
9 Pfizer 170.83 Bn 117.47 Bn 10.94 Bn
10 Nanoviricides 34.74 Mn 22.40 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2025 2,000.00
Sep 30, 2024 2,000.00
Sep 30, 2023 2,000.00
Sep 30, 2022 2,000.00
Sep 30, 2021 2,000.00
Sep 30, 2020 2,000.00
Jun 30, 2020 -4,000.00
Mar 31, 2020 2,000.00
Dec 31, 2019 2,000.00
Sep 30, 2019 2,000.00
Jun 30, 2011 -42,265.00
Mar 31, 2011 42,265.00
API Access

Nanoviricides Other Operating Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-operating-expenses&ticker=NNVC&period=max&api_key=YOUR_API_KEY